Good morning, everyone, and thank you for joining us this morning and for standing by. I'd like to take this opportunity to welcome you all to the I-Mab Biopharma Mid-Year 2023 Financial Results and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results